MIRA INFORM REPORT

 

 

Report No. :

357231

Report Date :

28.12.2015

 

IDENTIFICATION DETAILS

 

Name :

CADILA PHARMACEUTICALS LIMITED

 

 

Registered Office :

Cadila Corporate Campus, Sarkhej Dhokla Road, Ahmedabad – 380008, Gujarat

Tel. No.:

91-2718-225001

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

28.02.1991

 

 

Com. Reg. No.:

04- 015132

 

 

Capital Investment / Paid-up Capital :

Rs.845.739 Million

 

 

CIN No.:

[Company Identification No.]

U24231GJ1991PLC015132

 

 

IEC No.:

0895001390

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACC6251E

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceuticals Products. (From Indirect Sources)

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (63)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 9500000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 1991 having good track.

 

Available financial indicates sound financial risk profile marked by sound net worth base with low borrowings recorded and favorable gap between trade payables and trade receivables.

 

The ratings further continue to drive strength from its experienced management in the pharmaceutical industry with long-standing track record of business operation.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

In view of long track record and sound financial base, the company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities : A

Rating Explanation

Adequate degree of safety and carry low credit risk.

Date

12.02.2015

 

Rating Agency Name

CARE

Rating

Short term bank facilities : A1

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

12.02.2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 


 

LOCATIONS

 

Registered/ Corporate Office :

Cadila Corporate Campus, Sarkhej Dhokla Road, Ahmedabad – 380008, Gujarat, India

Tel. No.:

91-2718-225001 (15 Lines)

Fax No.:

91-2718-225039

E-Mail :

secretarial@cadilapharma.co.in  

Website :

http://www.cadilapharma.com

Location :

Owned

Factory 1 :

Dholka – Manufacturing Plant

Survey No. 1389, Trasad Road, Dholka, Ahmedabad – 387810, Gujarat, India

Tel. No:

91-79-23421841 / 83 / 84 / 23422006 / 7 / 8 / 9 / 10

Fax No:

91-79-23420315

 

 

Factory 2 :

Chemical SBU

294, GIDC Estate, Ankleshwar, Gujarat, India

Tel. No:

91-2646-223846/ 252626/ 251519 

Fax No:

91-2646-250051

 

 

Factory 3 :

CHPL – Factory / Karnavati Engineering Limited

Survey No. 342, Nani Kadi, Taluka Kadi, District Mehsana,   North Gujarat, India

Tel. No:

91-2764-262463/ 242037/ 242194/ 241464-65

Fax No:

91-2764-242223/ 242608

 

 

Factory 4 :

Chemicals SBU

Factory Plot No. 274, GIDC Industrial Estate, Ankleshwar, Gujarat, India

Tel. No:

91-2646-223846/ 252626/ 251519

Fax No:

91-2646-250051

 

 

Factory 5 :

Tissu Culture Lab

756, Prakruti Farm, Hirapur Chowkdi, Hirapur, Ahmedabad, Gujarat, India

Tel. No:

91-79-3855260/ 3855495/ 496

 

 

Factory 6 :

Cadila Pharmaceuticals Limited, Jammu

Industrial Growth Centre, Samba – 184121, District Jammu, Jammu and Kashmir, India

Tel. No:

91-1923-241113/ 241114/ 241115

Fax No:

91-1923-246744

 

 

DIRECTORS

 

AS ON 31.03.2015

 

Name :

Dr. Rajiv Indravadan Modi

Designation :

Managing director

Address :

13, Sanjiv Building, New Sharda Mandir Road, Paldi,  Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

09.05.1960

Qualification :

Ph. D (Biological Science), M. Sc (Biochemical Engineering), B. Tech(Chemical Engineering)

Date of Appointment :

01.07.2010

PAN No.:

AAPPM9265J

DIN No.:

01394558

 

 

Name :

Mr. Ramesh Ratilal Choksi

Designation :

Whole-time director

Address :

B-9, Indira Niwas, 82 Linking Road, Santacruz Police ST, Santacruz(West), Mumbai, 400054, Maharashtra, India

Date of Birth/Age :

 

Date of Appointment :

07.02.2014

DIN No.:

06636737

 

 

Name :

Mr. Daya Nand Khurana

Designation :

Director

Address :

288, Vasant Enclave, Vasant Vihar, New Delhi - 110057, India

Date of Birth/Age :

15.05.1935

Qualification :

B.E.(EC)

Date of Appointment :

04.07.2003

DIN No.:

00020601

 

 

Name :

Mr. Pradip Navin Khandwalla

Designation :

Director

Address :

B/101, Jupiter Tower, Opposite Samkit Bunglows, Bodakdev, Ahmedabad – 380054, Gujarat, India

Date of Birth/Age :

18.02.1940

Qualification :

B. Com. (Com), MBA (Wharton, Penn.), Ph.D. (Carnegie-Mellon), ACA

Date of Appointment :

14.09.2007

DIN No.:

00064643

 

 

Name :

Mrs. Monika Garware Modi

Designation :

Director

Address :

13, Sanjiv Building, New Sharda Mandir Road, Paldi,  Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

04.06.1963

Qualification :

M.B.A. from Pace University, New York, USA

Date of Appointment :

15.12.1995

PAN No.:

AEQPG3834C

DIN No.:

00143400

 

 

Name :

Mr. Chinubhai Ramanlal Shah

Designation :

Director

Address :

402, Heritage Cresent, Behind Prahladnagar Garden, Near Jain Derasar, S. G. Highway, Ahmedabad – 380051, Gujarat, India

Date of Birth/Age :

04.06.1937

Qualification :

M.A., L.L.M. (Gold Medalist), DLP, DTP, FCS, Life Fellow AIMA

Date of Appointment :

31.03.2001

DIN No.:

00558310

 

 

Name :

Mrs. Shilaben Indravadan Modi

Designation :

Director

Address :

13, Sanjiv Baug, New Sharda Mandir Road, Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

09.12.1931

Qualification :

Matriculate

Date of Appointment :

16.12.1995

PAN No.:

AEYPM8647R

DIN No.:

01976356

 

 

KEY EXECUTIVES

 

Name :

Amitabha Banerjee

Designation :

Chief Finance Officer

Address :

A-902, Prestige Tower, Off. Judges Bunglow Road,, Vastrapur, Ahmedabad - 380015, Gujarat, India

PAN No.:

AADPB0669D

Date of Appointment :

08.07.2014

 

 

Name :

Srinivas Kotra

Designation :

Secretary

Address :

M-101, Venus Parkland,, Vejalpur Road,, Ahmedabad - 380051, Gujarat, India

PAN No.:

AEVPK6767P

Date of Appointment :

23.03.2015

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 31.03.2015

 

Names of Shareholders [Equity Shares]

 

No. of Shares

Rajiv. I. Modi (Karta of I.A. Modi HUF)

 

10

Rajiv. I. Modi (Trustee of IRM Trust)

 

79999976

R. I. Modi (Trustee of Mansi Trust)

 

10

IRM Limited, India

 

1

Karnavati Engineering Limited, India

 

1

Green Channel Logi Solutions Limited, India

 

1

Monikaben Modi

 

1

Total

 

80000000

 

Names of Shareholders [Preference Shares]

 

No. of Shares

Rajiv I. Modi

 

44346

Monikaben Modi (Trustee of IRM Trust)

 

4465088

CPL Infrastructure Private Limited, India

 

49462

IRM Limited, India

 

5000

Karnavati Engineering Limited, India

 

5000

Inverika Bioresearch Private Limited, India

 

5000

 

 

 

Total

 

4573896

 

 

As on 24.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceuticals Products. (From Indirect Sources)

 

 

Products :

Product Description

Item Code No. (ITC Code)

Ethambutol

29051410

Ranitidine

29420014

Sulphameth Axazole

29350011

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

PRODUCTION STATUS: NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

Customers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

Banker Name

Not Available

Branch Address

Not Available

Person Name (With Designation)

Not Available

Contact Number

Not Available

Name of Account Holder

Not Available

Account Number

Not Available

Account Since (Date/Year of Account Opening)

Not Available

Average Balance Maintained (If Possible)

Not Available

Credit Facilities Enjoyed (If any)

Not Available

Account Operation

Not Available

Remarks (If any)

Not Available

 

 

Facilities :

(Rs. In Million)

 

SECURED LOAN

As on

31.03.2015

As on

31.03.2014

LONG TERM BORROWING

 

 

Rupee term loans from banks

2020.481

2637.000

Loans taken for vehicles

67.924

69.043

SHORT TERM BORROWING

 

 

Working capital loans from banks

1548.235

1600.558

Total

3636.64

4306.601

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

Heritage', 3rd Floor, Near Gujarat Vidypith, Off. Ashram Road, Ahmedabad – 380014, Gujarat, India

PAN N Income-tax PAN of auditor or auditor's firm :

AABFD7919A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management

personnel and their relatives:

A. J. Modi HUF-1

A. J. Modi HUF-2

A. J. Modi HUF-3

A. J. Modi HUF-4

A. J. Modi HUF-4

A. J. Modi HUF-5

A. J. Modi HUF-6

A. J. Modi HUF-7

  • Shilraj trust
  • Shilaben Family Trust
  • Dr. Rajiv Modi- HUF
  • Rajiv Family Trust
  • A. Modi Family Trust
  • Inverika Bioresearch Private Limited, India [U73100GJ2012PTC070636]
  • Casil Health Products Limited, India [U51909GJ1995PLC027839]
  • Casil Industries Limited, India [U24231GJ2000PLC038320]
  • CPL Infrastructure Private Limited, India [U67120GJ1995PTC025713]
  • IRM Limited
  • IRM Trust
  • Apollo Hospitals International Limited, India

 [U85110TN1997PLC039016]

  • Omni Care Pharmaceuticals Limited
  • I.A.Modi (H.U.F)-A/C no.2
  • I.A.Modi (H.U.F.)-A/C No.3
  • I.A.Modi (H.U.F)
  • A.J.Modi Family Trust
  • Indraj Trust
  • Manendra Family Trust
  • Mansi Family Trust
  • Manthan Family Trust
  • Mayur Family Trust
  • Mihir Family Trust
  • Raj Trust
  • Shantaben Family
  • Will Trust

 

 

Subsidiary company:

  • Cadila Pharmaceuticals (E.A.) Ltd., Kenya
  • C A D I L A Pharmaceuticals (Europe) Limited, United Kingdom
  • C A D I L A PHARMACEUTICALS SWEDEN AB
  • C a d i l a Pharmaceuticls(Ethiopia) Plc., Ethiopia
  • CPL Biologicals Private Limited, India [U01403GJ2009PTC056409]
  • C P L INC.
  • Interpharma Ltd, Nigeria
  • Irm Enterprises Private Limited, India [U74999GJ2009PTC058116]
  • Kadera Yakuhin Limited
  • Ka rnava t I Engineering Limited
  • La Vie Agricare Private Limited, India [U01403GJ2009PTC056669]
  • CPL HOLDINGS Private Limited, India [U65993GJ2009PTC056511]

 

 

Joint venture

  • Casil BG Medical Devices

 

 

Associate:

  • Green Channel Logi-Solutions Limited, India [U63023GJ2008PLC052813]

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80,000,000

Equity Shares

Rs.10/- each

Rs.800.000 Million

4,600,000

Preference Shares

Rs.10/- each

Rs.46.000 Million

 

Total

 

Rs.846.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80,000,000

Equity Shares

Rs.10/- each

Rs.800.000 Million

4,573,896

Preference Shares

Rs.10/- each

Rs.45.739 Million

 

Total

 

Rs.845.739 Million

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2015

31.03.2014

31.03.2013

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

845.739

845.739

800.000

(b) Reserves & Surplus

2482.649

2412.115

2649.738

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

45.739

Total Shareholders’ Funds (1) + (2)

3328.388

3257.854

3495.477

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

2675.324

3415.149

3355.522

(b) Deferred tax liabilities (Net)

411.830

529.632

533.130

(c) Other long term liabilities

333.901

260.128

238.196

(d) long-term provisions

63.799

39.443

34.082

Total Non-current Liabilities (3)

3484.854

4244.352

4160.930

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1548.235

1600.558

1657.343

(b) Trade payables

2542.245

1990.818

1898.366

(c) Other current liabilities

1136.704

963.911

1569.046

(d) Short-term provisions

377.745

253.511

161.642

Total Current Liabilities (4)

5604.929

4808.798

5286.397

 

 

 

 

TOTAL

12418.171

12311.004

12942.804

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

4946.568

5050.742

4936.297

(ii) Intangible Assets

18.756

17.719

24.766

(iii) Capital work-in-progress

517.921

698.521

653.876

(iv) Intangible assets under development

0.000

0.000

79.850

(b) Non-current Investments

966.673

659.726

1495.097

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

844.827

928.193

969.511

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

7294.745

7354.901

8159.397

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1779.343

1643.251

1563.096

(c) Trade receivables

2542.643

2195.103

2176.671

(d) Cash and cash equivalents

189.298

384.599

335.504

(e) Short-term loans and advances

578.954

701.839

644.456

(f) Other current assets

33.188

31.311

63.680

Total Current Assets

5123.426

4956.103

4783.407

 

 

 

 

TOTAL

12418.171

12311.004

12942.804

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

Income

13720.891

12522.565

10847.912

 

Other Income

217.386

256.378

120.054

 

TOTAL (A)

13938.277

12778.943

10967.966

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

4104.107

3591.936

3381.237

 

Purchases of Stock-in-Trade

1434.059

1199.359

883.621

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(117.900)

(53.160)

27.206

 

Employees benefits expense

2375.352

2201.805

1921.180

 

Other expenses

4188.996

3956.108

3042.351

 

Exceptional Items

0.000

0.000

452.480

 

CSR expenditure

22.230

0.000

0.000

 

TOTAL (B)

12006.844

10896.048

9708.075

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

1931.433

1882.895

1259.891

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

504.130

598.070

643.567

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

1427.303

1284.825

616.324

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

652.630

281.200

269.546

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

774.673

1003.625

346.778

 

 

 

 

 

Less

TAX (H)

121.821

24.203

46.324

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)   (I)

652.852

979.422

300.454

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

Export Earnings

4657.361

4665.156

3795.450

 

Other Earnings

41.566

35.520

20.712

 

TOTAL EARNINGS

4698.927

4700.676

3816.162

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

544.083

543.377

454.231

 

Stores & Spares

31.395

63.565

8.001

 

Capital Goods

72.177

16.254

73.167

 

TOTAL IMPORTS

647.655

623.196

535.399

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

8.00

12.00

3.76

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

748.248

513.522

990.430

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

1994.169

1547.986

1526.415

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

4.76

7.82

2.77

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

14.08

15.04

11.61

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.09

9.16

3.24

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.31

0.10

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.49

1.70

1.72

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.91

1.03

0.90

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

800.000

845.739

845.739

Reserves & Surplus

2649.738

2412.115

2482.649

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

45.739

0.000

0.000

Net worth

3495.477

3257.854

3328.388

 

 

 

 

long-term borrowings

3355.522

3415.149

2675.324

Short term borrowings

1657.343

1600.558

1548.235

Current maturities of long-term debts

990.430

513.522

748.248

Total borrowings

6003.295

5529.229

4971.807

Debt/Equity ratio

1.717

1.697

1.494

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

10847.912

12522.565

13720.891

 

 

15.438

9.569

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

10847.912

12522.565

13720.891

Profit

300.454

979.422

652.852

 

2.77%

7.82%

4.76%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 


 

OPERATING RESULTS

 

During the year, the Company has achieved the sales of Rs. 13406.500 Million which show the growth of 9% over the previous year (Rs.12279.300 Million). The operating profit for the year was Rs. 1931.400 Million as against Rs. 1882.900 Million in the previous year registering a growth of 2.5%.

 

The profits after tax for the year decreased to 652.900 Million as against Rs. 979.400 Million in the previous year.

 

During the year, the export of API and Formulations by the Company registered de-growth by 3.39% to Rs. 4604.700 Million as against Rs. 4766.500 Million in the previous year. Total exports during the year contribute 33.40% of total sales of the Company.

 

The Company is committed to introduce new products / molecules with its R&D efforts in the coming years and achieve substantial growth in sales as well as profitability.

 

SCHEME OF AMALGAMATION:

 

1.1 A Scheme of Amalgamation (the Scheme) under Section 391 to 394 of Companies Act,1956, for amalgamation of IRM Properties Private Limited ("IPPL" or "Transferor Company") into Cadila Pharmaceuticals Limited ("the Company"), was sanctioned by the Hon'ble High Court of Gujarat on 20th November,2013.The Scheme, which became operative from effective date i.e. 27th February, 2014 i.e. date of filling the certified copies of the Orders of the Hon'ble High Court of Gujarat, with the Registrar of Companies, Ahmedabad, Gujarat, was effective from the appointed date i.e. 25th March, 2013.

 

1.2 The Transferor Company was engaged in property business.

 

1.3 Pursuant to the Scheme, with effect from the Appointed date, the whole of the undertaking and assets, properties, debts, liabilities, duties and obligations of the Transferor Company have, under the provisions of Sections 391-394 and all applicable provisions, if any of the Act, without any further act or deed , stand transferred to and vested in and/or deemed to be transferred to and vested to Company, so as to become the business, assets and properties of Company as a part of and consequent upon the Scheme. The undertaking of Transferor have includes all the Transferor Company's Reserves, movable and immovable properties, assets, including lease-hold rights, tenancy rights, industrial and other licenses, registrations, permits, authorisations, quota rights, trade marks, patents and other industrial and intellectual properties, import quotas, electrical connections, telephones, telex, facsimile and other communication facilities and equipments, rights and benefits of all agreements, pending applications and all other interests, rights and powers of every kind, nature and description whatsoever, privileges, liberties, easements, advantages, benefits and approvals of the Transferor Company.

 

1.4 Pursuant to the Scheme, the authorised share capital of the Company consisting of Rs.800.000 Million comprising of 80.000 Million) equity shares of Rs.10/-each have automatically stand increased by the authorised share capital of Transferor Company amounting to Rs.46.000 Million.

 

1.5 In consideration for the amalgamation, the equity shareholders of IPPL, holding fully paid-up equity shares in IPPL on the effective date, 1 (one) fully paid up 0.01% Redeemable Non-Cumulative Preference Share of Rs.10/-each of the Company had been issued and allotted for every 10(Ten) equity share of Rs 1 held in IPPL.

 

1.6 All the employees of IPPL in service as on effective date have become employee of the Company without any break or interruption in their service on same terms and conditions on which they were engaged as on the effective date. Company further agrees that for the purpose of payment of any retirement benefit/compensation, such immediate uninterrupted past services with the Transferor Company, as the case may be, shall also be taken into account. The Company undertakes to continue to abide by the terms of agreement /settlement entered into by the Transferor company with employees' union/ employee or associations as the case may be.

 

1.7 The amalgamation had been accounted as per "Amalgamation in the nature of Purchase" as prescribed in Accounting Standard 14 - "Accounting for Amalgamation" . Accordingly, the Company had recorded all the assets and liabilities appearing in the books of account of IPPL and transferred to and vested in the Company at their respective fair values as determined by board of directors of the Company as on the effective date. The fair value of the land and building was as certified by the independent valuer and for other assets and liabilities was based on managements assessment of its recoverability and liability for payment. The difference between the excess of the Net Assets Value of IPPL transferred to and recorded by the Company and face value of Preference shares allotted, have been credited to Securities Premium account of the Company. "Net Assets Value" is the fair value of assets less fair value of liabilities of the Transferor Company transferred to the Company.

 

1.8 Pursuant to the Scheme, with effect from Appointed Date and for any of the financial years ending on or after the Appointed Date, if considered appropriate by the Board of Directors of the Company, any or all of the Extraordinary and Exceptional items may be adjusted against the General Reserves of the Company. “Extraordinary and / or Exceptional items” means : (a) Impairment, amortization and / or write off / diminution in value of investments and other assets, both tangible and intangible including goodwill, if any, (b) Costs/ expenses / charge / losses on account of write down or transfer of assets or contingent liabilities or deferred tax liabilities which may be suffered by or be required to be accounted by CPL, pursuant to this Scheme or otherwise in the course of its business or in carrying out such restructuring of the operations of CPL as the Board of Directors of CPL consider necessary or proper, (c) Any other costs/ expenses / charge / losses / liabilities which in the opinion of the Board of Directors are extraordinary and exceptional.1.9 In pursuant to Scheme, the Board of Directors of the Company has approved for write off of Rs 119.930 Million comprises of debtors Rs 58.600 Million, investment Rs 47.500 Million Stock Rs.13.830 Million (Previous year Rs.936.256 Million comprises of debtors Rs.75.902 Million, investment Rs 719.616 Million. loans and advances Rs 38.104 Million-, Intangible Assets Rs. 79.850 Million, Stock Rs.22.785 Million) in Board meeting dated 7th August 2015 (Previous year Board meeting dated 8th July 2014 ) and to transfer the similar amount from the balance of General Reserve of Company to Statement of Profit and Loss.

 

UNSECURED LOAN

 

(Rs. In Million)

Particulars

As on

31.03.2015

As on

31.03.2014

LONG TERM BORROWING

 

 

Bonds/debentures

300.000

300.000

Deposits from others

3.992

78.064

Public deposits

0.000

0.013

Loans and advances from others

9.109

0.000

Other loans and advances, others

273.818

331.029

Total

586.919

709.106

 


 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10490013

25/03/2014

350,000,000.00

EXPORT-IMPORT BANK OF INDIA

EXPORT-IMPORT BANK OF INDIA, CENTRE ONE BUILDING,
FLOOR 21, WTC COMPLEX,, MUMBAI, MAHARASHTRA - 400
005, INDIA

C03360146

2

10481788

10/02/2014

1,250,000,000.00

BANK OF BARODA

CORPORATE FINANCIAL SERVICES BRANCH, 1ST FLOOR,,
BOB TOWERS, OPP. LAW GARDEN, ELLISBRIDGE,, AHMEDAB
AD, GUJARAT - 380009, INDIA

B98178411

3

10466339

29/11/2013

500,000,000.00

UNION BANK OF INDIA

IFB, C. U. SHAH CHAMBERS,, ASHRAM ROAD,, AHMEDABA
D, GUJARAT - 380014, INDIA

B92018449

4

10384789

17/10/2012

500,000,000.00

BANK OF BARODA

CORPORATE FINANCIAL SERVICES BRANCH, BANK OF BARO
DA TOWERS, ELLISBRIDGE, AHMEDABAD, GUJARAT - 38000
6, INDIA

B61496022

5

10349308

09/04/2012

420,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE
COMPLEX, CUFFE PARADE,, MUMBAI, MAHARASHTRA - 400
005, INDIA

B37458825

6

10329665

20/12/2011

650,000,000.00

BANK OF BARODA

CORPORATE FINANCIAL SERVICES BRANCH, BANK OF BARO
DA TOWERS, ELLISBRIDGE, AHMEDABAD, GUJARAT - 38000
6, INDIA

B29858016

7

10284330

21/08/2013 *

500,000,000.00

INDIAN OVERSEAS BANK

401, 403 SIGMA LEGACY, NR. POLYTECHNIC CROSS ROAD
, IIRM ROAD, AHMEDABAD, GUJARAT - 380015, INDIA

B84319458

8

10260601

21/12/2010

480,000,000.00

BANK OF BARODA

CORPORATE FINANCIAL SERVICES BRANCH,, BANK OF BAR
ODA TOWERS, ELLISBRIDGE,, AHMEDABAD, GUJARAT - 380
006, INDIA

B03237732

9

10157250

08/04/2009

2,550,000.00

DEPARTMENT OF BIOTECHNOLOGY

BLOCK 2, CGO COMPLEX, LODHI ROAD, NEW DELHI, DELH
I - 110003, INDIA

A61567855

10

10090235

31/01/2008

4,320,000.00

HDFC BANK LIMITED

HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL W
, MUMBAI, MAHARASHTRA - 400013, INDIA

A33032723

* Date of charge modification

 

FIXED ASSETS

 

Tangible assets

 

  • Land
  • Furniture and fixtures
  • Plant and equipment
  • Vehicles
  • Office equipment

 

Intangible assets

 

  • Computer software

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.66.20

UK Pound

1

Rs.98.30

Euro

1

Rs.72.41

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

KVT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.